VITANA-X INC. AND SUBSIDIARY
CONSOLIDATED INTERIM FINANCIAL STATEMENTS
Three months ended October 31, 2021 and 2020
(Unaudited)
VITANA-X INC. AND SUBSIDIARY
CONSOLIDATED INTERIM FINANCIAL STATEMENTS
Three months ended October 31, 2021 and 2020
(Unaudited)
CONTENTS | |
Consolidated Interim Balance Sheets | 3 |
Consolidated Interim Statement of Operations | 4 |
Consolidated Interim Statement of Changes in Shareholders' Equity (Deficit) | 5 |
Consolidated Interim Statement of Cash Flows | 6 |
Notes to the Consolidated Interim Financial Statements | 7 |
2
VITANA-X INC. AND SUBSIDIARY
CONSOLIDATED INTERIM BALANCE SHEETS Three months ended October 31, 2021 and 2020 (Unaudited)
October 31, | July 31, | ||
in USD | Notes | 2021 | 2021 |
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Receivables due from credit card processor
Inventory
Other current receivables due from related parties
Other current assets
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS | |||||
Fixed assets (net of depreciation) | |||||
Intangible assets (net of amortization) | 4 | ||||
TOTAL NON-CURRENT ASSETS | |||||
TOTAL ASSETS | |||||
LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||
CURRENT LIABILITIES | |||||
Accounts payable | |||||
Financial liabilities | 5 | ||||
Provisions | |||||
Other current liabilities | |||||
TOTAL CURRENT LIABILITIES | |||||
NON-CURRENT LIABILITIES | |||||
Financial liabilities | 5 | ||||
Financial liabilities due to directors | 5 | ||||
Financial liabilities - Convertible notes payable | 5 | ||||
TOTAL NON-CURRENT LIABILITIES | |||||
TOTAL LIABILITIES | |||||
STOCKHOLDERS' DEFICIENCY | |||||
Series A Preferred Stock; $0.0001 par value; 1,000,000 designated; | 6.3 | ||||
1,000,000 shares issued (July 31, 2021: NIL) | |||||
Series B Preferred Stock; $0.0001 par value; 1,344,756 shares designated; | 6.4 | ||||
NIL shares issued (July 31, 2021: 1,344,756 ) | |||||
Common Stock; $0.0001 par value; 5,000,000,000 shares authorized; | 6.1 | ||||
2,968,279,672 shares issued (July 31, 2021: 1,366,002,045) | |||||
Additional paid-in capital | |||||
Reserve for unissued shares | |||||
Cumulative translation adjustment | |||||
Accumulated deficit | |||||
TOTAL STOCKHOLDERS' DEFICIT | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
27,146 | 23,035 | ||||
29,366 | 40,019 | ||||
464,602 | 434,250 | ||||
75,424 | 74,553 | ||||
51,581 | 36,702 | ||||
648,119 | 608,559 | ||||
35,648 | 40,525 | ||||
56,933 | 170,799 | ||||
92,581 | 211,324 | ||||
740,700 | 819,883 | ||||
267,000 | 342,001 | ||||
181,501 | 191,252 | ||||
223,234 | 224,563 | ||||
168,536 | 157,739 | ||||
840,271 | 915,555 | ||||
129,920 | 135,224 | ||||
181,974 | - | ||||
91,568 | 297,473 | ||||
403,462 | 432,697 | ||||
1,243,733 | 1,348,252 | ||||
100 | - | ||||
134 | |||||
- | |||||
296,828 | 136,600 | ||||
3,952,142 | 2,185,778 | ||||
739,316 | 2,166,314 | ||||
(5,102) | (5,906) | ||||
(5,486,317) | (5,011,289) | ||||
(503,033) | (528,369) | ||||
740,700 | 819,883 |
See accompanying notes to the consolidated interim financial statements (unaudited).
3
VITANA-X INC. AND SUBSIDIARY
CONSOLIDATED INTERIM STATEMENT OF OPERATIONS
Three months ended October 31, 2021 and 2020
(Unaudited)
Three months ended October 31, | |||||
in USD | Notes | 2021 | 2020 | ||
Revenues | 301,519 | - | |||
Cost of goods sold | (210,223) | - | |||
Gross profit | 91,296 | - | |||
Operating expenses | |||||
General and administrative | 299,475 | 19,209 | |||
Depreciation and amortization | 4 | 116,060 | - | ||
Professional fees | 230,902 | 233,150 | |||
Total operating expenses | 646,437 | 252,359 | |||
LOSS FROM OPERATIONS | (555,141) | (252,359) | |||
Other income (expenses) | |||||
Fair value changes of derivative financial instruments | - | 255,399 | |||
Gain (loss) from foreign currency transactions | (1,495) | - | |||
Other financial expenses | (3,892) | - | |||
Total Other Income (Expenses) | (5,387) | 255,399 | |||
NET LOSS | (560,528) | 3,040 | |||
NET LOSS PER COMMON SHARE | 7 | ||||
Basic and diluted | (0.00) | 0.00 | |||
Weighted average number of shares outstanding | 2,064,859,167 | 1,260,038,783 |
See accompanying notes to the consolidated interim financial statements (unaudited).
4
VITANA-X INC. AND SUBSIDIARY
CONSOLIDATED INTERIM STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)
Three months ended October 31, 2021 and 2020
(Unaudited)
Additional | Reserve for | Cumulative | Total | |||||||||
Series A Preferred | Series B Preferred | Common Stock | Paid-in | Unissued | Translation | Accumulated | Shareholders' | |||||
in USD | Notes | Number | Amount | Number | Amount | Number | Amount | Capital | Shares | Adjustment | Deficit | Deficit |
Balance at July 31, 2021 | - | - | 1,344,756 | 134 | 1,366,002,045 | 136,600 | 2,185,778 | 2,166,314 | (5,906) | (5,011,289) | (528,369) | |
Net loss for the interim period | - | - | - | - | - | - | - | - | - | (560,528) | (560,528) | |
Foreign currency translation | - | - | - | - | - | - | - | - | 804 | - | 804 | |
Total other comprehensive income | - | - | - | - | - | - | - | - | 804 | (560,528) | (559,724) |
Issuance of Series A Preferred Stock for previous period transactions
Issuance of Common Stock for conversion of notes
Exchange of Series B Preferred Stock for Common Stock
Cash received for the issuance of Common Stock
Common Stock granted for services
Settlement of convertible notes
6.3 | 1,000,000 | 100 | - | - | - | - | - | (100) | - | - | - |
6.1 | - | - | - | - | 714,722,430 | 71,472 | 1,854,986 | (1,926,458) | - | - | - |
6.1 | - | - | (1,344,756) | (134) | 887,555,197 | 88,756 | (88,622) | - | - | - | - |
6.1 | - | - | - | - | - | - | - | 298,655 | - | - | 298,655 |
6.1 | - | - | - | - | - | - | - | - | - | 85,500 | 85,500 |
5 | - | - | - | - | - | - | - | 200,905 | - | - | 200,905 |
Balance at October 31, 2021 | 1,000,000 | 100 | - | - | 2,968,279,672 | 296,828 | 3,952,142 | 739,316 | (5,102) | (5,486,317) | (503,033) |
Additional | Reserve for | Cumulative | Total | |||||||||||
Common Stock | Paid-in | Unissued | Translation | Accumulated | Shareholders' | |||||||||
in USD | Notes | Number | Amount | Capital | Shares | Adjustment | Deficit | Deficit | ||||||
Balance at July 31, 2020 | 435,482,400 | 43,548 | 1,373,074 | 223,219 | - | (2,493,563) | (853,722) | |||||||
Net loss for the interim period | - | - | - | - | - | 3,040 | 3,040 | |||||||
Issuance of Common Stock for conversion of notes | 919,019,645 | 91,902 | 495,233 | - | - | - | 587,135 | |||||||
Balance at October 31, 2020 | 1,354,502,045 | 135,450 | 1,868,307 | 223,219 | - | (2,490,523) | (263,547) | |||||||
See accompanying notes to the consolidated interim financial statements (unaudited).
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Vitana-X Inc. published this content on 12 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 December 2021 15:05:06 UTC.